144 related articles for article (PubMed ID: 35793384)
1. Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival.
Hackert T; Klaiber U; Hinz U; Strunk S; Loos M; Strobel O; Berchtold C; Kulu Y; Mehrabi A; Müller-Stich BP; Schneider M; Büchler MW
Ann Surg; 2023 Jun; 277(6):e1291-e1298. PubMed ID: 35793384
[TBL] [Abstract][Full Text] [Related]
2. Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection.
Glebova NO; Hicks CW; Piazza KM; Abularrage CJ; Cameron AM; Schulick RD; Wolfgang CL; Black JH
J Vasc Surg; 2015 Aug; 62(2):424-33. PubMed ID: 25953018
[TBL] [Abstract][Full Text] [Related]
3. Portal vein resection in pancreatic neuroendocrine neoplasms.
Nießen A; Klaiber U; Lewosinska M; Nickel F; Billmann F; Hinz U; Büchler MW; Hackert T
Surgery; 2024 Apr; 175(4):1154-1161. PubMed ID: 38262817
[TBL] [Abstract][Full Text] [Related]
4. Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma.
Terasaki F; Fukami Y; Maeda A; Takayama Y; Takahashi T; Uji M; Kaneoka Y
Langenbecks Arch Surg; 2019 Mar; 404(2):191-201. PubMed ID: 30631907
[TBL] [Abstract][Full Text] [Related]
5. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
[TBL] [Abstract][Full Text] [Related]
6. Postoperative Outcomes of Tangential
Lapshyn H; Schulte T; Petruch N; Petrova E; Honselmann K; Deichmann S; Braun R; Kulemann B; Hoeppner J; Rades D; Keck T; Wellner UF; Bausch D; Bolm L
Anticancer Res; 2021 Oct; 41(10):5123-5130. PubMed ID: 34593463
[TBL] [Abstract][Full Text] [Related]
7. Portal Vein Thrombosis After Venous Reconstruction During Pancreatectomy: Timing and Risks.
Roch AM; Kilbane EM; Nguyen T; Ceppa EP; Zyromski NJ; Schmidt CM; Nakeeb A; House MG
J Gastrointest Surg; 2022 Oct; 26(10):2148-2157. PubMed ID: 35819666
[TBL] [Abstract][Full Text] [Related]
8. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension.
Bachellier P; Rosso E; Fuchshuber P; Addeo P; David P; Oussoultzoglou E; Lucescu I
Surgery; 2014 Mar; 155(3):449-56. PubMed ID: 24462078
[TBL] [Abstract][Full Text] [Related]
9. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
[TBL] [Abstract][Full Text] [Related]
10. Routine portal vein resection for pancreatic adenocarcinoma shows no benefit in overall survival.
Klein F; Berresheim F; Felsenstein M; Malinka T; Pelzer U; Denecke T; Pratschke J; Bahra M
Eur J Surg Oncol; 2018 Jul; 44(7):1094-1099. PubMed ID: 29778616
[TBL] [Abstract][Full Text] [Related]
11. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
[No Abstract] [Full Text] [Related]
12. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
13. Technical Strategy for Pancreatic Body Cancers: A Raison d'etre of Distal Pancreatectomy with Portal Resection.
Maekawa A; Oba A; Inoue Y; Omiya K; Ono Y; Sato T; Watanabe S; Uchino Y; Kobayashi K; Ito H; Sato Y; Tanabe M; Saiura A; Takahashi Y
Ann Surg Oncol; 2024 Feb; 31(2):1347-1357. PubMed ID: 37952022
[TBL] [Abstract][Full Text] [Related]
14. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis.
Machairas N; Raptis DA; Velázquez PS; Sauvanet A; Rueda de Leon A; Oba A; Koerkamp BG; Lovasik B; Chan C; Yeo CJ; Bassi C; Ferrone CR; Kooby D; Moskal D; Tamburrino D; Yoon DS; Barroso E; de Santibañes E; Kauffmann EF; Vigia E; Robin F; Casciani F; Burdío F; Belfiori G; Malleo G; Lavu H; Hartog H; Hwang HK; Han HS; Marques HP; Poves I; Domínguez-Rosado I; Park JS; Lillemoe KD; Roberts K; Sulpice L; Besselink MG; Abuawwad M; Del Chiaro M; de Santibañes M; Falconi M; D'Silva M; Silva M; Hilal MA; Qadan M; Sell NM; Beghdadi N; Napoli N; Busch ORC; Mazza O; Muiesan P; Müller PC; Ravikumar R; Schulick R; Powell-Brett S; Abbas SH; Mackay TM; Stoop TF; Gallagher TK; Boggi U; van Eijck C; Clavien PA; Conlon KCP; Fusai GK
Ann Surg; 2021 Nov; 274(5):721-728. PubMed ID: 34353988
[TBL] [Abstract][Full Text] [Related]
16. International Study Group of Pancreatic Surgery type 3 and 4 venous resections in patients with pancreatic adenocarcinoma:the Paoli-Calmettes Institute experience.
Al Faraï A; Garnier J; Ewald J; Marchese U; Gilabert M; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O
Eur J Surg Oncol; 2019 Oct; 45(10):1912-1918. PubMed ID: 31186204
[TBL] [Abstract][Full Text] [Related]
17. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
18. Portal vein reconstruction using primary anastomosis or venous interposition allograft in pancreatic surgery.
Kleive D; Berstad AE; Sahakyan MA; Verbeke CS; Naper C; Haugvik SP; Gladhaug IP; Line PD; Labori KJ
J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):66-74. PubMed ID: 29128301
[TBL] [Abstract][Full Text] [Related]
19. Interposition graft with polytetrafluoroethylene for mesenteric and portal vein reconstruction after pancreaticoduodenectomy.
Stauffer JA; Dougherty MK; Kim GP; Nguyen JH
Br J Surg; 2009 Mar; 96(3):247-52. PubMed ID: 19224515
[TBL] [Abstract][Full Text] [Related]
20. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
Katou S; Wenning AS; Aeschbacher P; Morgul H; Becker F; Pascher A; Gloor B; Strücker B; Andreou A
Surgery; 2023 Jul; 174(1):91-99. PubMed ID: 37121858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
